Publicaciones en las que colabora con ANA BARABASH BUSTELO (11)

2023

  1. Early visual alterations in individuals at-risk of Alzheimer’s disease: a multidisciplinary approach

    Alzheimer's Research and Therapy, Vol. 15, Núm. 1

  2. Exploratory Longitudinal Study of Ocular Structural and Visual Functional Changes in Subjects at High Genetic Risk of Developing Alzheimer’s Disease

    Biomedicines, Vol. 11, Núm. 7

2022

  1. The relationship between retinal layers and brain areas in asymptomatic first-degree relatives of sporadic forms of Alzheimer’s disease: an exploratory analysis

    Alzheimer's Research & Therapy, Vol. 14, Núm. 1

2016

  1. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study

    Journal of Alzheimer's Disease, Vol. 52, Núm. 1, pp. 133-143

2013

  1. The role of alleles 4 and 2 of the APOE gene and cognitive tests in the early conversion of mild cognitive impairment to alzheimer dementia

    Alzheimer's Disease Research Compendium (Nova Science Publishers, Inc.), pp. 279-293

2011

  1. The role of alleles 4 and 2 of the APOE gene and cognitive tests in the early conversion of mild cognitive impairment to Alzheimer dementia

    Alzheimer's Disease Research Journal, Vol. 3, Núm. 3-4, pp. 277-291

2009

  1. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease

    Neurobiology of Aging, Vol. 30, Núm. 8, pp. 1254-1264

2006

  1. Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease

    American Journal of Alzheimer's Disease and other Dementias, Vol. 21, Núm. 3, pp. 189-196

  2. The role of functional neuroimaging in mild cognitive impairment

    Current Medical Imaging Reviews, Vol. 2, Núm. 2, pp. 237-246

2004

  1. Relevance of functional neuroimaging in the progression of mild cognitive impairment

    Neurological Research, Vol. 26, Núm. 5, pp. 496-501

2003

  1. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 30, Núm. 11, pp. 1473-1480